Somatostatin receptor expression in Hürthle cell cancer of the thyroid.
J Nucl Med
; 39(2): 243-5, 1998 Feb.
Article
in En
| MEDLINE
| ID: mdl-9476928
ABSTRACT
Somatostatin receptor expression, which was not a previously described marker for Hürthle cell cancer of the thyroid, was demonstrated by in vivo imaging with (111)In-pentetreotide in three patients. This phenomenon not only adds another imaging technique to the nuclear medicine armamentarium for detecting recurrent and metastatic cancer in patients with Hürthle cell cancer but also opens up an alternative therapeutic avenue with somatostatin analogs or their radiolabeled compounds.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thyroid Neoplasms
/
Receptors, Somatostatin
/
Adenoma, Oxyphilic
Limits:
Aged
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Nucl Med
Year:
1998
Document type:
Article
Affiliation country:
Estados Unidos